{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T12:01:17Z","timestamp":1790510477964,"version":"4.1.0"},"reference-count":105,"publisher":"Bioscientifica","issue":"8","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":["erc.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,8]]},"abstract":"<jats:p>\n                    Evidence supports a role of 17&amp;-estradiol (E\n                    <jats:sub>2<\/jats:sub>\n                    ) in carcinogenesis and the large majority of breast carcinomas are dependent on estrogen. The anti-estrogen tamoxifen (TAM) is widely used for both treatment and prevention of breast cancer; however, it is also carcinogenic in human uterus and rat liver, highlighting the profound complexity of its actions. The nature of E\n                    <jats:sub>2<\/jats:sub>\n                    - or TAM-induced chromosomal damage has been explored using relatively high concentrations of these agents, and only some numerical aberrations and chromosomal breaks have been analyzed. This study aimed to determine the effects of low doses of E\n                    <jats:sub>2<\/jats:sub>\n                    and TAM (10\n                    <jats:sup>&amp;8\u2009<\/jats:sup>\n                    mol\u2009L\n                    <jats:sup>&amp;1<\/jats:sup>\n                    and 10\n                    <jats:sup>&amp;6\u2009<\/jats:sup>\n                    mol\u2009L\n                    <jats:sup>&amp;1<\/jats:sup>\n                    respectively) on karyotypes of MCF7, T47D, BT474, and SKBR3 breast cancer cells by comparing the results of conventional karyotyping and multi-FISH painting with cell proliferation. Estrogen receptor (ER)-positive (+) cells showed an increase in cell proliferation after E\n                    <jats:sub>2<\/jats:sub>\n                    treatment (MCF7, T47D, and BT474) and a decrease after TAM treatment (MCF7 and T47D), whereas in ER&amp; cells (SKBR3), no alterations in cell proliferation were observed, except for a small increase at 96\u2009h. Karyotypes of both ER+ and ER&amp; breast cancer cells increased in complexity after treatments with E\n                    <jats:sub>2<\/jats:sub>\n                    and TAM leading to specific chromosomal abnormalities, some of which were consistent throughout the treatment duration. This genotoxic effect was higher in HER2+ cells. The ER&amp;\/HER2+ SKBR3 cells were found to be sensitive to TAM, exhibiting an increase in chromosomal aberrations. These\n                    <jats:italic>in vitro<\/jats:italic>\n                    results provide insights into the potential role of low doses of E\n                    <jats:sub>2<\/jats:sub>\n                    and TAM in inducing chromosomal rearrangements in breast cancer cells.\n                  <\/jats:p>","DOI":"10.1530\/erc-16-0078","type":"journal-article","created":{"date-parts":[[2016,6,29]],"date-time":"2016-06-29T23:34:03Z","timestamp":1467243243000},"page":"635-650","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-1","source":"Crossref","is-referenced-by-count":11,"title":["Effect of low doses of estradiol and tamoxifen on breast cancer cell karyotypes"],"prefix":"10.1530","volume":"23","author":[{"given":"Milena","family":"Rond\u00f3n-Lagos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson","family":"Rangel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovica Verdun","family":"Di Cantogno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Annaratone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Castellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalia","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilde","family":"Manetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Marchi\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Sapino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"2016080418232349000_23.8.635.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-4608(01)00475-7"},{"key":"2016080418232349000_23.8.635.2","doi-asserted-by":"publisher","DOI":"10.1016\/S1383-5718(99)00230-2"},{"key":"2016080418232349000_23.8.635.3","doi-asserted-by":"publisher","DOI":"10.1515\/BC.2005.102"},{"key":"2016080418232349000_23.8.635.4","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-3458"},{"key":"2016080418232349000_23.8.635.5","first-page":"8820","article-title":"The FOXP1 winged helix transcription factor is a novel candidate tumor suppressor gene on chromosome 3p","volume":"61","author":"Banham","year":"2001","journal-title":"Cancer Research"},{"key":"2016080418232349000_23.8.635.6","doi-asserted-by":"publisher","DOI":"10.1126\/science.6262919"},{"key":"2016080418232349000_23.8.635.7","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/oxfordjournals.epirev.a036116","article-title":"Endogenous hormones and breast cancer risk","volume":"15","author":"Bernstein","year":"1993","journal-title":"Epidemiologic Reviews"},{"key":"2016080418232349000_23.8.635.8","doi-asserted-by":"publisher","DOI":"10.1038\/nature08822"},{"key":"2016080418232349000_23.8.635.9","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.83.8.2496"},{"key":"2016080418232349000_23.8.635.10","doi-asserted-by":"publisher","DOI":"10.1038\/nature08768"},{"key":"2016080418232349000_23.8.635.11","first-page":"3866","article-title":"FHIT loss of function in human primary breast cancer correlates with advanced stage of the disease","volume":"59","author":"Campiglio","year":"1999","journal-title":"Cancer Research"},{"key":"2016080418232349000_23.8.635.12","doi-asserted-by":"publisher","DOI":"10.1016\/0022-4731(89)90368-3"},{"key":"2016080418232349000_23.8.635.13","doi-asserted-by":"publisher","DOI":"10.5483\/BMBRep.2011.44.7.423"},{"key":"2016080418232349000_23.8.635.14","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20304"},{"key":"2016080418232349000_23.8.635.15","first-page":"162","article-title":"ERalpha-negative and triple negative breast cancer: molecular features and potential therapeutic approaches","volume":"1796","author":"Chen","year":"2009","journal-title":"Biochimica et Biophysica Acta"},{"key":"2016080418232349000_23.8.635.16","first-page":"892","article-title":"Retrograde transport of the transmembrane estrogen receptor, G-protein-coupled-receptor-30 (GPR30\/GPER) from the plasma membrane towards the nucleus","volume":"76","author":"Cheng","year":"2011","journal-title":"Steroids"},{"key":"2016080418232349000_23.8.635.17","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-0760(00)00040-6"},{"key":"2016080418232349000_23.8.635.18","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-005-0429-9"},{"key":"2016080418232349000_23.8.635.19","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.09.004"},{"key":"2016080418232349000_23.8.635.20","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-009-9260-6"},{"key":"2016080418232349000_23.8.635.21","doi-asserted-by":"publisher","DOI":"10.1038\/nature10983"},{"key":"2016080418232349000_23.8.635.22","doi-asserted-by":"publisher","DOI":"10.1088\/2057-1739\/1\/2\/025001"},{"key":"2016080418232349000_23.8.635.23","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-2027"},{"key":"2016080418232349000_23.8.635.24","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgp307"},{"key":"2016080418232349000_23.8.635.25","doi-asserted-by":"publisher","DOI":"10.1677\/erc.0.0060181"},{"key":"2016080418232349000_23.8.635.26","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djk020"},{"key":"2016080418232349000_23.8.635.27","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0140-6736(92)90997-H","article-title":"Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women.","volume":"339","author":"Early Breast Cancer Trialists\u2019 Collaborative Group","year":"1992","journal-title":"Lancet"},{"key":"2016080418232349000_23.8.635.28","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)11423-4"},{"key":"2016080418232349000_23.8.635.29","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60993-8"},{"key":"2016080418232349000_23.8.635.30","doi-asserted-by":"publisher","DOI":"10.1016\/S0955-0674(99)00085-X"},{"key":"2016080418232349000_23.8.635.31","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-006-9476-5"},{"key":"2016080418232349000_23.8.635.32","doi-asserted-by":"publisher","DOI":"10.1007\/s10577-013-9368-6"},{"key":"2016080418232349000_23.8.635.33","doi-asserted-by":"publisher","DOI":"10.1038\/nature10762"},{"key":"2016080418232349000_23.8.635.34","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-1823"},{"key":"2016080418232349000_23.8.635.35","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1139\/G06-023","article-title":"Clonal and non-clonal chromosome aberrations and genome variation and aberration","volume":"49","author":"Heng","year":"2006","journal-title":"Genome"},{"key":"2016080418232349000_23.8.635.36","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.107.016568"},{"key":"2016080418232349000_23.8.635.37","doi-asserted-by":"publisher","DOI":"10.1006\/geno.1997.4981"},{"key":"2016080418232349000_23.8.635.38","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M705937200"},{"key":"2016080418232349000_23.8.635.39","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210289"},{"key":"2016080418232349000_23.8.635.40","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.0783"},{"key":"2016080418232349000_23.8.635.41","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2298\/AOO0604122I","article-title":"Role of transforming growth factor-\u00df1 in breast carcinogenesis","volume":"14","author":"Ivanovic","year":"2006","journal-title":"Archive of Oncology"},{"key":"2016080418232349000_23.8.635.42","doi-asserted-by":"publisher","DOI":"10.15208\/mhsj.2010.100"},{"key":"2016080418232349000_23.8.635.43","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.05.145"},{"key":"2016080418232349000_23.8.635.44","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgg001"},{"key":"2016080418232349000_23.8.635.45","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1211"},{"key":"2016080418232349000_23.8.635.46","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-009-0500-4"},{"key":"2016080418232349000_23.8.635.47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0084532"},{"key":"2016080418232349000_23.8.635.48","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrgentox.2010.08.016"},{"key":"2016080418232349000_23.8.635.49","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3346\/jkms.2011.26.3.352","article-title":"The expression of ERCC1, RRM1, and BRCA1 in breast cancer according to the immunohistochemical phenotypes","volume":"26","author":"Kim","year":"2011","journal-title":"Journal of Korean Medical Science"},{"key":"2016080418232349000_23.8.635.50","doi-asserted-by":"publisher","DOI":"10.1023\/A:1024581508474"},{"key":"2016080418232349000_23.8.635.51","first-page":"4025","article-title":"Expression of MMPs and TIMPs genes in human breast cancer epithelial cells depends on cell culture conditions and is associated with their invasive potential","volume":"24","author":"Kousidou","year":"2004","journal-title":"Anticancer Research"},{"key":"2016080418232349000_23.8.635.52","doi-asserted-by":"crossref","first-page":"812540","DOI":"10.4061\/2011\/812540","article-title":"The dynamic structure of \u2028the estrogen receptor","volume":"2011","author":"Kumar","year":"2011","journal-title":"Journal of Amino Acids"},{"key":"2016080418232349000_23.8.635.53","doi-asserted-by":"publisher","DOI":"10.1186\/1755-8794-4-41"},{"key":"2016080418232349000_23.8.635.54","first-page":"130","article-title":"HSPB1 (Heat-Shock 27 kDa Protein 1).","volume":"14","author":"Laskowska","year":"2010","journal-title":"Atlas of Genetics and Cytogenetics \u2028in Oncology and Haematology"},{"key":"2016080418232349000_23.8.635.55","doi-asserted-by":"publisher","DOI":"10.1186\/bcr3233"},{"key":"2016080418232349000_23.8.635.56","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2015.02.011"},{"key":"2016080418232349000_23.8.635.57","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0408273101"},{"key":"2016080418232349000_23.8.635.58","doi-asserted-by":"publisher","DOI":"10.1210\/me.2009-0148"},{"key":"2016080418232349000_23.8.635.59","doi-asserted-by":"publisher","DOI":"10.1210\/er.21.1.40"},{"key":"2016080418232349000_23.8.635.60","first-page":"1","article-title":"BCL10 (B-cell CLL\/lymphoma 10)","volume":"12","author":"Lin","year":"2009","journal-title":"Atlas of Genetics and Cytogenetics in Oncology and Haematology"},{"key":"2016080418232349000_23.8.635.61","doi-asserted-by":"publisher","DOI":"10.2741\/1546"},{"key":"2016080418232349000_23.8.635.62","doi-asserted-by":"publisher","DOI":"10.4161\/cc.27378"},{"key":"2016080418232349000_23.8.635.63","doi-asserted-by":"publisher","DOI":"10.1186\/bcr1279"},{"key":"2016080418232349000_23.8.635.64","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2150"},{"key":"2016080418232349000_23.8.635.65","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/sj.onc.1200999","article-title":"Suppression of tumorigenicity of breast cancer cells by an epithelial cell adhesion molecule (C-CAM1): the adhesion and growth suppression are mediated by different domains","volume":"14","author":"Luo","year":"1997","journal-title":"Oncogene"},{"key":"2016080418232349000_23.8.635.66","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197508)36:2+<638::AID-CNCR2820360805>3.0.CO;2-S"},{"key":"2016080418232349000_23.8.635.67","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-03-3489"},{"key":"2016080418232349000_23.8.635.68","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.31.21528"},{"key":"2016080418232349000_23.8.635.69","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.04.024"},{"key":"2016080418232349000_23.8.635.70","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.22413"},{"key":"2016080418232349000_23.8.635.71","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603433"},{"key":"2016080418232349000_23.8.635.72","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2003.09.003"},{"key":"2016080418232349000_23.8.635.73","doi-asserted-by":"publisher","DOI":"10.1172\/JCI29852"},{"key":"2016080418232349000_23.8.635.74","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-1373"},{"key":"2016080418232349000_23.8.635.75","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.10696"},{"key":"2016080418232349000_23.8.635.76","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrgentox.2007.10.021"},{"key":"2016080418232349000_23.8.635.77","doi-asserted-by":"publisher","DOI":"10.1038\/372143a0"},{"key":"2016080418232349000_23.8.635.78","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2136"},{"key":"2016080418232349000_23.8.635.79","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2012.01.029"},{"key":"2016080418232349000_23.8.635.80","doi-asserted-by":"publisher","DOI":"10.1177\/002215549704500705"},{"key":"2016080418232349000_23.8.635.81","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007239"},{"key":"2016080418232349000_23.8.635.82","doi-asserted-by":"publisher","DOI":"10.1186\/1755-8166-7-8"},{"key":"2016080418232349000_23.8.635.83","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-922"},{"key":"2016080418232349000_23.8.635.84","first-page":"667","article-title":"Allelic imbalance at 11q23-q24 chromosome associated with estrogen and radiation-induced breast cancer progression","volume":"28","author":"Roy","year":"2006","journal-title":"International Journal of Oncology"},{"key":"2016080418232349000_23.8.635.85","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2006.09.004"},{"key":"2016080418232349000_23.8.635.86","first-page":"2526","article-title":"Estrogen- and tamoxifen-induced rearrangement of cytoskeletal and adhesion structures in breast cancer MCF-7 cells","volume":"46","author":"Sapino","year":"1986","journal-title":"Cancer Research"},{"key":"2016080418232349000_23.8.635.87","doi-asserted-by":"publisher","DOI":"10.1248\/cpb.40.182"},{"key":"2016080418232349000_23.8.635.88","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-03-0729"},{"key":"2016080418232349000_23.8.635.89","doi-asserted-by":"publisher","DOI":"10.4161\/cc.9.22.13746"},{"key":"2016080418232349000_23.8.635.90","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2007.03.021"},{"key":"2016080418232349000_23.8.635.91","unstructured":"Shaffer LG McGowan-Jordan J Schmid M 2013 ISCN: An International System for Human Cytogenetic Nomenclature. Basel, Switzerland: \u2028S. Karger."},{"key":"2016080418232349000_23.8.635.92","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2013.04.025"},{"key":"2016080418232349000_23.8.635.93","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djh166"},{"key":"2016080418232349000_23.8.635.94","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.25.1.220-232.2005"},{"key":"2016080418232349000_23.8.635.95","doi-asserted-by":"publisher","DOI":"10.1210\/me.2006-0474"},{"key":"2016080418232349000_23.8.635.96","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-9-31"},{"key":"2016080418232349000_23.8.635.97","doi-asserted-by":"publisher","DOI":"10.1210\/en.2004-1064"},{"key":"2016080418232349000_23.8.635.98","doi-asserted-by":"publisher","DOI":"10.2307\/3433380"},{"key":"2016080418232349000_23.8.635.99","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-010-9363-z"},{"key":"2016080418232349000_23.8.635.100","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2006.11.013"},{"key":"2016080418232349000_23.8.635.101","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2014.08.006"},{"key":"2016080418232349000_23.8.635.102","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra050776"},{"key":"2016080418232349000_23.8.635.103","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1593\/neo.101088","article-title":"Identification of H-Ras-specific motif for the activation of invasive signaling program in human breast epithelial cells","volume":"13","author":"Yong","year":"2011","journal-title":"Neoplasia"},{"key":"2016080418232349000_23.8.635.104","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-5-57"},{"key":"2016080418232349000_23.8.635.105","doi-asserted-by":"publisher","DOI":"10.1101\/gad.229559.113"}],"container-title":["Endocrine-Related Cancer"],"original-title":[],"link":[{"URL":"https:\/\/erc.bioscientifica.com\/view\/journals\/erc\/23\/8\/635.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/erc.bioscientifica.com\/downloadpdf\/journals\/erc\/23\/8\/635.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:53:35Z","timestamp":1784555615000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/erc\/article\/23\/8\/635-650\/26981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":105,"journal-issue":{"issue":"8"},"URL":"https:\/\/doi.org\/10.1530\/erc-16-0078","relation":{},"ISSN":["1351-0088","1479-6821"],"issn-type":[{"value":"1351-0088","type":"print"},{"value":"1479-6821","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8]]}}}